Citrus compound d-limonene put to the test against radiation-induced dry mouth

NCT ID NCT04392622

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This phase 1 trial tests whether d-limonene, a compound found in citrus peel, can safely prevent severe dry mouth (xerostomia) in people with head and neck cancer undergoing radiation and chemotherapy. Participants take d-limonene capsules daily during their standard cancer treatment. The study primarily looks at safety and tolerability, checking for side effects that could delay radiation or require dose reductions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a dietary supplement called d-limonene, a compound found in citrus peel
What this could lead to
If safe and effective, d-limonene could offer a simple, low-cost way to prevent severe dry mouth in people undergoing radiation for head and neck cancer.
What could go wrong
This is an early phase 1 trial with only 40 participants, focused on safety. It is too small to prove whether d-limonene actually prevents dry mouth, and side effects like diarrhea or abdominal pain are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Stanford University

    RECRUITING

    Stanford, California, 94305, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.